CERGENTIS
Cergentis provides services and kits based on its proprietary 'Targeted Locus Amplification' (TLA) technology. Cergentis’ mission is to contribute to the quality of genetic research and human healthcare by providing services and kits that enable the cost-effective complete sequencing of relevant genes and genomic loci. Cergentis was established in 2012 as a spin-off from the Royal Netherlands Academy of Arts and Sciences (KNAW) and its Hubrecht Institute for Developmental Biology & Stem Cell Research. Cergentis works with and for leading research institutes, diagnostic labs and pharmaceutical and biotech companies globally.
CERGENTIS
Industry:
Biotechnology Genetics Medical
Founded:
2012-01-01
Address:
Utrecht, Utrecht, The Netherlands
Country:
The Netherlands
Website Url:
http://www.cergentis.com
Total Employee:
11+
Status:
Active
Contact:
+31 (0)30 760 16 36
Email Addresses:
[email protected]
Total Funding:
1.85 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Apache Mobile Non Scaleable Content
Current Advisors List
Current Employees Featured
Founder
Investors List
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - Cergentis
Key Employee Changes
| Date | New article |
|---|---|
| 2020-06-29 | Cergentis Appoints New CEO and Board Members |
Official Site Inspections
http://www.cergentis.com Semrush global rank: 3.75 M Semrush visits lastest month: 3.61 K
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Cergentis"
Cergentis Is Now Part of Solvias | Find Cergentis Services
Cergentis is part of Solvias. We’ve brought our Targeted Locus Amplification (TLA) technology platform and expertise in genetic characterization and QC to Solvias to support development …See details»
Cergentis is Now Solvias NL
Jul 2, 2024 Erik Splinter, General Manager of former Cergentis, now Solvias NL shared: "The journey of integration into the Solvias organization has been incredibly fruitful. As Solvias NL, …See details»
Cergentis - Crunchbase Company Profile & Funding
May 1, 2018 Cergentis was. established in 2012 as a spin-off from the Royal Netherlands Academy of Arts and Sciences (KNAW) and its Hubrecht Institute for Developmental Biology & …See details»
Solvias Acquires Cergentis to Bolster Biologics and Cell & Gene …
Jul 12, 2022 Leading Global Analytical Laboratory Expands Testing Solutions to Support Development of Safe & Effective Advanced Therapies News Summary Solvias, one of the …See details»
Solvias Acquires Cergentis to Bolster Biologics and Cell & Gene …
Jul 12, 2022 Cergentis is a trusted genomics-focused biotechnology company providing services and in-house solutions based on its proprietary genomic analysis platform to all leading …See details»
Solvias Acquires Cergentis for Added Biologic and Cell & Gene …
Jul 12, 2022 With the addition of Cergentis, Solvias’ CEO Archie Cullen says the company will continue to support the increasing number of global pharmaceutical, biotech, and CDMOs …See details»
Solvias Acquires Cergentis to Bolster Biologics and Cell
July 12, 2022 Solvias Acquires Cergentis to Bolster Biologics and Cell & Gene Therapy Capabilities. Kaiseraugst, Switzerland – Solvias, one of the world’s leading independent …See details»
Hubrecht spin-off Cergentis acquired by Solvias
Jul 13, 2022 Cergentis is a leading provider of genetic quality control solutions, based on its proprietary Targeted Locus Amplification (TLA) technology platform. They support research …See details»
Solvias acquires Cergentis - 2022-07-12 - Crunchbase
Jul 12, 2022 Cergentis Cergentis provides services and kits based on its proprietary 'Targeted Locus Amplification' (TLA) technology. Acquiring Organization: Solvias Solvias provides …See details»
Solvias Acquires Cergentis to Bolster Biologics and Cell
Jul 12, 2022 Solvias, one of the world’s leading independent pharmaceutical testing and manufacturing companies, announced today that it has acquired Utrecht, Netherlands-based …See details»
Solvias has acquired Utrecht, Netherlands-based Cergentis
Jul 13, 2022 Cergentis is a trusted genomics-focused biotechnology company providing services and in-house solutions based on its proprietary genomic analysis platform to all leading …See details»
Solvias Acquires Dutch Genomics Firm Cergentis | GenomeWeb
Jul 12, 2022 Cergentis has been providing services based on its genomic analysis platform to biopharmaceutical firms and research institutions. About a year ago, the Utrecht, Netherlands …See details»
Cergentis - Products, Competitors, Financials, Employees, …
Cergentis' Targeted Locus Amplification (TLA) Technology uniquely enables the targeted complete Next Generation Sequencing of any genomic locus in any genome of interest. The …See details»
Solvias Acquires Cergentis to Bolster Biologics and Cell & Gene …
News Summary Solvias, one of the world’s leading independent pharmaceutical testing and manufacturing companies, has acquired Netherlands-based Cergentis to bolster its biologics …See details»
Cergentis Company Profile 2024: Valuation, Investors ... - PitchBook
Cergentis General Information Description. Provider of genomics study services intended to improve the quality of genetic research and human healthcare. The company's services and …See details»
Genetic Quality Control Testing | Cergentis + Solvias
With our proprietary Targeted Locus Amplification (TLA) platform developed by Cergentis, we can conduct complete and targeted gene sequencing to facilitate the detection of all single …See details»
Cergentis - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . May 1, 2018: Grant - Cergentis …See details»
Cergentis Company Profile - Office Locations, Competitors ... - Craft
Cergentis is a genomics company specializing in precision medicine. It provides services and kits based on its proprietary Targeted Locus Amplification technology to diagnostic labs, research …See details»
Cergentis - Contacts, Employees, Board Members, Advisors
Organization. Cergentis . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. ... Cergentis has 2 board members and …See details»
Cergentis on track with product development of TLA-based …
With the help of the EU Horizon 2020 grant received last year, our product development team is making fantastic progress with TLA-based protocols on FFPE tumour samples.. By combining …See details»